Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KCT0006877Phase 4Completed
A Phase 4 trial of remimazolam, propofol in delirium, Neoplasm, None, sponsored by Hana Pharm. Started Aug 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on KCT0006877.